Carbon Nanotube Research and Development Alliances With Nanocyl

Topics Covered

Background

Specific Target Research Project (STREP)

Nanofire

Nanohybrid

Carbonchip

Nanogene

NanoImpact

Integrated Projects (IP)

Ambio

Inteltex

Collective Research Projects

Nanomed

Specific Support Action Projects (SSA)

Nanotox

Background

Nanocyl is one of the key players in the carbon nanotube (CNT) industry. To ensure and even improve this strong position, Nanocyl has the research support and technology transfer from 13 University Laboratories and Institutes: Ecole Nationale Supérieure de Chimie Lille, Technologie- Entwickelingsgruppe, Ecole Nationale Supérieure des Arts et Industries Textiles, Université catholique de Louvain, CSL, UMH, CRIF-WTCM, Materia Nova, IPF, Université de Liège, Université de Technologie, Imec and Université de Namur.

Furthermore, Nanocyl has 9 Research and Development (R&D) European funded projects running or under negotiation, combining forces with a large number of international industry and University partners.

Specific Target Research Project (STREP)

Nanofire

The main purpose of Nanofire is to develop new classes of polymer nanocomposites and hybrid materials with fire retardant properties. The key partners for this project are Fiat, Tolsa and Leistritz. The universities of London, Mons, Lyon, Perugia and Budapest are collaborating on the Nanofire project.

Nanohybrid

The major objective of Nanohybrid is to develop fundamental knowledge in order to be able to elaborate new melt processable nanophase-separated hybrid materials with controlled architecture, derived from low cost petrochemical olefin feedstocks without sacrificing easy polymer melt processing. Partnering on this project are Basell Poliolefine, Sasol, Fiat, CEA and the Universities of Aachen, Mons, Freiburg and Bratislava.

Carbonchip

Carbonchip will address the potential of the integrated carbon nanotube technology through an interdisciplinary approach based on the R&D in catalysis, the growth of CNTs, the technology of CNTs on-chip, the related analysis methodology for control of properties and the CNT device for nano electronics. Working together on this project are Intel, Alchimer and the Universities of Leuven and Grenoble.

Nanogene

This project is in negotiation, addressing the exploitation of novel forms of carbon as innovative delivery systems for gene transfer applications. Nanocyl can count on the partnership of Theraptosis, MoleculArt and the Universities of London, Trieste and Brno.

NanoImpact

In collaboration with Kodak, Nanobiotix, Biomar and the Universities of Milano, Bar-Ilan and Frankfurt this project is to develop and integrate novel magnetic nano-materials with targeting molecules to obtain a new targeted drug-delivery system.

Integrated Projects (IP)

Ambio

The objective of the Ambio project is to develop innovatory, non-biocidal solutions to the problems of aquatic biofouling, using a range of molecular surface engineering approaches. The project will be Europe’s first, large-scale, multidisciplinary research program to meet the problem of marine biofouling and will be a ‘flagship’ for European non-biocidal, anti-fouling R&D. This project is made possible thanks to different partners of Nanocyl, including BASF, Akzo-Nobel, Argus Chemicals, Teer Coatings, the Universities of Heidelberg, Lindkoping, Dresden and Pisa.

Inteltex

Eurodye, International Color, Protensice, Castros & Marques are the key industry partners for this project. Nanocyl also has the support of different University partners, such as Roubaix, Lorient, London, Dresden, Lodz and Ipra for this project, developing a radically new approach to obtain intelligent textile combining three innovative functions: measurement in a continuous way of mechanical stresses applied to the textile structure, thermal self regulated textile surfaces, and detection of chemicals.

Collective Research Projects

Nanomed

The goal of this project is to develop a carbon nanotube actuator for use in medical technology. Carbon nanotubes have shown to act as “artificial muscles”, which possess an enormous potential in technical and medical applications. Compared to other actuator materials, their characteristics of large extensions at an enormously low energy supply with a high efficiency and a surprisingly low weight show their unique capabilities as actuator material. The wide field of possible medical applications will lead to dramatic changes in the health care system. To realize this project, Nanocyl has the full support of different partners such as Neue Materialen Würzburg, Ortopedijo Technika and the University of Fraunhofer.

Specific Support Action Projects (SSA)

Nanotox

With the help of three partners (CMP Scientifica, University of Helsinki and University of Manchester), the global aim of this project is to provide investigative support for the elucidation of the toxicological impact of nanoparticles on human health and the environment.

It is thanks to this large number of alliances that Nanocyl can continue to innovate and grow to become the market leader in the industry of producing carbon nanotubes and commercializing these products.

Source: Nanocyl

For more information on this source please visit Nanocyl

 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NANOCYL SA. (2017, July 31). Carbon Nanotube Research and Development Alliances With Nanocyl. AZoNano. Retrieved on October 08, 2024 from https://www.azonano.com/article.aspx?ArticleID=1957.

  • MLA

    NANOCYL SA. "Carbon Nanotube Research and Development Alliances With Nanocyl". AZoNano. 08 October 2024. <https://www.azonano.com/article.aspx?ArticleID=1957>.

  • Chicago

    NANOCYL SA. "Carbon Nanotube Research and Development Alliances With Nanocyl". AZoNano. https://www.azonano.com/article.aspx?ArticleID=1957. (accessed October 08, 2024).

  • Harvard

    NANOCYL SA. 2017. Carbon Nanotube Research and Development Alliances With Nanocyl. AZoNano, viewed 08 October 2024, https://www.azonano.com/article.aspx?ArticleID=1957.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.